On the recordSeptember 16, 2015
Given the similarity between FDA's draft guidance and the World Health Organization's scheme on biologics qualifiers, it would be important to consult with a WHO in arriving at a global solution.
Source
congress.govEditor's note · Context
Senator Hatch emphasizes the need for global consultation with WHO on drug naming.
Share
More from Orrin Hatch
Nov 27, 2018
I thank my dear colleague for his kind remarks. I didn't expect them. I didn't realize this was going on until a few minutes ago. So I am grateful to him. Thanks for that. The PRESIDING OFFICER. The Senator from Pennsylvania.
Nov 27, 2018
the Finance Committee has worked with the Treasury Department to ensure proper responsiveness to committee inquiries. We are continuing to review these matters to determine what further oversight is required.
Sep 25, 2018
These tariffs cause American manufacturers and farmers to pay more to conduct business and consumers to pay more to buy these things.
Nov 27, 2018
I am grateful to my colleagues and especially my colleague from Louisiana for his kind remarks on the floor of the U.S. Senate. It means so much to me. I want him to know that. I want the others to realize how much I appreciated their…
Other voices in this conversation
